<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the most common human <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, characteristically has a t(14; 18) interchromosomal translocation </plain></SENT>
<SENT sid="1" pm="."><plain>It is typically an indolent disease comprised of small resting B cells, but frequently develops into a high-grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The t(14; 18) translocates the Bcl-2 gene, generating a deregulated Bcl-2-immunoglobulin fusion gene </plain></SENT>
<SENT sid="3" pm="."><plain>Bcl-2 is a novel inner <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane protein that extends the survival of certain cells by blocking programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>To determine the oncogenic potential of the t(14; 18) translocation, we produced transgenic mice bearing a Bcl-2-immunoglobulin minigene that structurally mimicked the t(14; 18) </plain></SENT>
<SENT sid="5" pm="."><plain>An indolent <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> in these transgenic mice progressed to a malignant diffuse large-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The long latency, progression from polyclonal to monoclonal disease, and histological conversion, are <z:hpo ids='HP_0000001'>all</z:hpo> suggestive of secondary changes </plain></SENT>
<SENT sid="7" pm="."><plain>Half of the <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> high-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> had a rearranged c-myc gene </plain></SENT>
<SENT sid="8" pm="."><plain>Our transgenic mice provide an animal model for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> in t(14; 18) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and show that prolonged B-cell life increases <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> incidence </plain></SENT>
</text></document>